2,000
Participants
Start Date
October 30, 2023
Primary Completion Date
June 30, 2026
Study Completion Date
December 31, 2026
7-0940
A non-hormonal and non-steroidal gel that supports vulvovaginal mucosal conditions and speeds up recovery post vaginal rejuvenation. It is a suitable alternative to vaginally administered estrogen and topical corticosteroids, that promotes a moist healing environment leading to faster re-epithelialization. The gel relieves symptoms such as itchiness, tenderness, dryness, burning sensation, painful intercourse (dyspareunia), painful urination (dysuria), rectal and defecating pain. It improves erythema, mucosal tissue thinning, erosions, fissures, ulcerations, scarring/adhesions and swelling. It is indicated for long-term use to maintain the health of the vaginal mucosa without the side effects of vaginally administered hormonal therapy and topical corticosteroids.
RECRUITING
WR-Carolina Institute for Clinical Research, Fayetteville
RECRUITING
Southern Urogynecology, West Columbia
NOT_YET_RECRUITING
WR-Charleston Clinical Trials, LLC, Charleston
NOT_YET_RECRUITING
WR-Mount Vernon Clinical Research, LLC, Sandy Springs
NOT_YET_RECRUITING
WR-Multi-Specialty Research Associates, Lake City
NOT_YET_RECRUITING
WR-Medical Research Center of Memphis, LLC, Memphis
RECRUITING
WR-Global Medical Research, LLC, Dallas
NOT_YET_RECRUITING
WR-Clinical Research Center of Nevada, LLC, Las Vegas
NOT_YET_RECRUITING
WR-PRI, LLC (Los Alamitos), Los Alamitos
NOT_YET_RECRUITING
WR-Women's Health Care Research, LLC, San Diego
ACTIVE_NOT_RECRUITING
Orange Coast Women's Medical Group, Laguna Hills
RECRUITING
WR-PRI, LLC (Newport Beach), Newport Beach
Stratpharma AG
INDUSTRY